Epsilon M&A Deal Report - Over the Counter, Intellectual Property and Trading Assets of Melmed Group
Transaction Multiples for the Valuation of Private Companies
BioProgress / Over the Counter, Intellectual Property and Trading Assets of Melmed Group
No EMAT :
17734
Announced Date :
27/06/2007
Type :
Acquisition of Majority Stake
Deal Value :
Yes
Acquirer :
BioProgress
Target :
Over the Counter, Intellectual Property and Trading Assets of Melmed Group
Country :
Europe
Sector of activity :
- Pharmaceuticals & Cosmetics > Health, Pharmaceuticals & Biotechnology > Pharmaceuticals
Business Description :
Melbrosin is an over the counter specialist . It develops and distributes products based upon substances of natural and plant origin. > Melbrosin’s offers food and dietary supplements for medical...
Transaction multiples available
| EV/ Sales |
EV/ Gross Profit |
EV/ EBITDA |
EV/ EBIT |
Eq/ PBT |
P/E | Price to Book |
Specific multiple(s) |
|
|---|---|---|---|---|---|---|---|---|
| Historic | 
|
|||||||
| Current |
|
Rating :
*
|
|
Multiple available |
| n.s. | Multiple calculated, but not significant |
Source: Epsilon Research / EMAT
Comparable Transactions
- Number of EMAT Reports / sub-sector « Pharmaceuticals » = 131
| Date | Acquirer | Target | Country | Multiples | See details |
| 05/04/2007 | Omega Pharma | Persee Medica | France | ** | 17728 |
| 25/04/2007 | Private Group Led by AXA Private Equity Fund | SynerLAB France | France | * | 17725 |
Source: Epsilon Research / EMAT
